OMRON Ventures Co., Ltd. (headquartered in Minato-Ku, Tokyo. CEO: Tomoko Inoue) is pleased to announce that it has made an investment in Visby Medical, Inc. (headquartered in California, United States. CEO: Adam de la Zerda), which develops and sells the world’s first disposable portable PCR testing devices. This is the first investment made from the OVC II Investment Limited Partnership that OMRON and Omron Ventures established on January 31, 2022.
For details, please refer to the press release of OMRON Corporation.